Boost basal metabolic function with improved hormone signaling
What they found: Oral AOD-9604 reduced body fat by 18 to 22 % vs placebo, comparable to injection administration No changes in total body weight (because lean mass rose slightly) Decrease in plasma triglycerides by 30 % Decrease in resting free fatty acids (paradoxically, mobilization of fat from depots into oxidation) No GI side effects Why it matters: It suggested that AOD-9604 could work orally , a rare property for a peptide
Matching expectations to your specific condition prevents premature disappointment
It's death
The maximum approved dose may be different if retatrutide is licensed in the future
If you have neurological symptoms (pins and needles, numbness, balance issues), severe fatigue, unexplained weight loss, chest pain, breathlessness, or symptoms that are worsening, you should seek medical assessment promptly.